Article Authors: L A Morrow, M Hompesch, S J Jacober, S Leng Choi, Y Qu, V P Sinha
Abstract
To compare, in an open-label, randomized, crossover phase II substudy, the glucodynamics of insulin glargine and those of basal insulin peglispro (BIL) in patients with type 1 diabetes.